Clinical Trial Update: IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing IMRT plus cisplatin to conventional radiotherapy plus cisplatin in stage III-IV head and neck squamous cell carcinoma (oral/oropharyngea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Oral Cancer
• Oropharyngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Oral Cancer, Oropharynx Cancer | Phase 3 | Status: COMPLETED